AMGNon logo

Amgen Inc (AMGN)

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease;...

NASDAQHealthcareDrug Manufacturers - GeneralUSA

公司简介

股票代码
AMGN
ISIN代码
US0311621009
货币
US Dollar (USD)
IPO日期
1983-06-17

联系信息

公司地址
One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799
联系电话
805 447 1000
公司网站
https://www.amgen.com
财年结束
December

财务亮点

市值
$999,999.99
毛利润(TTM)
$999,999.99
股息收益率
2.92%
资产回报率(TTM)
8.35%
EBITDA
$999,999.99
收入(TTM)
$999,999.99